Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wuling San for Breast Cancer-related Lymphedema
NCT02726477Unknown
- Sponsor
- Fourth Affiliated Hospital of Guangxi Medical University
- Start
- Apr 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in lymphedema comparing Wuling San with Placebo (2 arms). Primary endpoint: Percentage of limb volume changes at 8 weeks. Status: unknown.
02
Drugs
oreongsan
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT02726477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726477.